Share This Article:

Debulking of Keloid Combined with Intralesional Injection of 5-Flurouracil and Triamcinolone versus Intralesional Injection of 5-Flurouracil and Triamcinolone

Abstract Full-Text HTML Download Download as PDF (Size:305KB) PP. 85-91
DOI: 10.4236/jcdsa.2014.42013    3,548 Downloads   5,259 Views   Citations

ABSTRACT

Background: A wide range of therapies exist for keloids. But despite the multiple treatment modalities available, keloids still remain a significant challenge for both the clinician and the patient. Objective: To assess the effectiveness and safety of debulking of keloid with intralesional injection of 5-flurouracil and triamcinolone in comparison to intralesional injection of 5-flurouracil and triamcinolone alone. Patient and Methods: This single blinded comparative therapeutic outpatient based study was done at the Department of Dermatology, Baghdad Teaching Hospital during the period from February 2011 to February 2013. Twenty-three patients with 52 lesions were enrolled in the study and consisted of two groups: Group A (26 lesions): Treated by intralesional injection of combination of 5-flurouracil and triamcinolone acetonide and repeated every month; Group B (26 lesions): Debulking was carried out first and then injection of combination of 5-flurouracil and triamcinolone acetonide at time of operation and then repeated injection monthly. Evaluation was performed by scoring system with 5 criteria (redness, elevation, hardness, itching and tenderness). The response was graded as no response, minimal, moderate or complete response. Results: Both modalities of treatments showed significant results in treating keloid, but the intralesional therapy alone was slightly better than debulking plus intralesional and no systemic adverse effects were noticed in both groups. Conclusion: Both modalities of therapy were effective in treatment of keloid, and there was no much difference between them.

Cite this paper

Sharquie, K. , Noaimi, A. and Al-Karhi, M. (2014) Debulking of Keloid Combined with Intralesional Injection of 5-Flurouracil and Triamcinolone versus Intralesional Injection of 5-Flurouracil and Triamcinolone. Journal of Cosmetics, Dermatological Sciences and Applications, 4, 85-91. doi: 10.4236/jcdsa.2014.42013.

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1] Atiyeh, B.S., Costagliola, M. and Hayek, S.N. (2005) Keloid or Hypertrophic Scar: The Controversy: Review of the Literature. Annals of Plastic Surgery, 54, 676-680. http://dx.doi.org/10.1097/01.sap. 0000164538.72375.93
[2] Butler, P.D., Longaker, M.T. and Yang, G.P. (2008) Current Progress in Keloid Research and Treatment. Journal of the American College of Surgeons, 206, 731-741. http://dx.doi.org/10.1016/ j.jamcollsurg.2007.12.001
[3] Marneros, A.G., Norris, J.E., Olsen, B.R., et al. (2001) Clinical Genetics of Familial Keloids. Archives of Dermatology, 137, 1429-1434. http://dx.doi.org/10.1001/archderm.137.11.1429
[4] Mustoe, T.A., Cooter, R.D., Gold, M.H., Hobbs, F.D., Ramelet, A.A., Shakespeare, P.G., et al. (2002) International Clinical Recommendations on Scar Management. Plastic and Reconstructive Surgery, 110, 560-571. http://dx.doi.org/10.1097/00006534-200208000-00031
[5] Shaffer, J.J., Taylor, S.C. and Cook-Bolden, F. (2002) Keloidal Scars: A Review with a Critical Look at Therapeutic Options. Journal of the American Academy of Dermatology, 46, S63-S97.
http://dx.doi.org/10.1067/mjd.2002.120788
[6] Gauglitz, G.G. and Kunte, C. (2011) Recommendations for the Prevention and Therapy of Hypertrophic Scars and Keloids. Hautarzt, 62, 337-346. http://dx.doi.org/10.1007/s00105-010-2087-4
[7] Berman, B., Villa, A. and Ramirez, C. (2005) Novel Opportunities in the Treatment and Prevention of Scarring. Journal of Cutaneous Medicine and Surgery, 8, 32-36.
[8] Berman, B., Perez, O.A. and Konda, S. (2007) A Review of the Biologic Effects, Clinical Efficacy, and Safety of Silicone Elastomer Sheeting for Hypertrophic and Keloid Scar Treatment and Management. Dermatologic Surgery, 33, 1291-1303. http://dx.doi.org/10.1111/j.1524-4725.2007.33280.x
[9] Niessen, F., Spauwen, P., Schalkwijk, J. and Kon, M. (1999) On the Nature of Hypertrophic Scars and Keloids: A Review. Plastic and Reconstructive Surgery, 104, 1435-1458. http://dx.doi.org/10.1097/ 00006534-199910000-00031
[10] Chuangsuwanich, A. and Gunjittisomrarn, S. (2007) The Efficacy of 5% Imiquimod Cream in the Prevention of Recurrence of Excised Keloids. Journal of the Medical Association of Thailand, 90, 1363-1367.
[11] Agbenorku, P. (2000) Triple Keloid Therapy: A Combination of Steroids, Surgery and Silicone Gel Strip/Sheet for Keloid Treatment. European Journal of Plastic Surgery, 23, 150-151.
http://dx.doi.org/10.1007/s002380050236
[12] Alster, T.S. (1994) Improvement of Erythematous and Hypertrophic Scars by the 585-nm Flashlamp-Pumped Pulsed Dye Laser. Annals of Plastic Surgery, 32, 186-190. http://dx.doi.org/10.1097/ 00000637-199402000-00015
[13] Jalali, M. and Bayat, A. (2007) Current Use of Steroids in Management of Abnormal Raised Skin Scars. Surgeon, 5, 175-180. http://dx.doi.org/10.1016/S1479-666X(07)80045-X
[14] Poochareon, V.N. and Berman, B. (2003) New Therapies for the Management of Keloids. Journal of Craniofacial Surgery, 14, 654-657. http://dx.doi.org/10.1097/00001665-200309000-00009
[15] Asilian, A., Darougheh, A. and Shariati, F. (2006) New Combination of Triamcinolone, 5-Fluorouracil, and Pulsed-Dye Laser for Treatment of Keloid and Hypertrophic Scars. Dermatologic Surgery, 32, 907-915. http://dx.doi.org/10.1111/j.1524-4725.2006.32195.x
[16] Darougheh, A., Asilian, A. and Shariati, F. (2009) Intralesional Triamcinolone Alone or in Combination with 5-Fluorouracil for the Treatment of Keloid and Hypertrophic Scars. Clinical and Experimental Dermatology, 34, 219-223. http://dx.doi.org/10.1111/j.1365-2230.2007.02631.x
[17] Robles, D.T. and Berg, D. (2007) Abnormal Wound Healing: Keloids. Clinics in Dermatology, 25, 26-32. http://dx.doi.org/10.1016/j.clindermatol.2006.09.009
[18] Apikian, M. and Goodman, G. (2004) Intralesional 5-Fluorouracil in the Treatment of Keloid Scars. Australasian Journal of Dermatology, 45, 140-143. http://dx.doi.org/10.1111/j.1440-0960.2004.000 72.x
[19] Saha, A.K. and Mukhopadhyay, M. (2012) A Comparative Clinical Study on Role of 5-Flurouracil versus Triamcinolone in the Treatment of Keloids. Indian Journal of Surgery, 74, 326-329.
http://dx.doi.org/10.1007/s12262-011-0399-y
[20] Chuangsuwanich, A. and Gunjittisomrarn, S. (2007) The Efficacy of 5% Imiquimod Cream in the Prevention of Recurrence of Excised Keloids. Journal of the Medical Association of Thailand, 90, 1363-1367. http://www.annalsplasticsurgery.com/
[21] Alster, T.S. (1994) Improvement of Erythematous and Hypertrophic Scars by the 585-nm Flashlamp-Pumped Pulsed Dye Laser. Annals of Plastic Surgery, 32, 186-190. http://dx.doi.org/10.1097/ 00000637-199402000-00015
[22] Sanders, K.W., Gage-White, L. and Stucker, F.J. (2005) Topical Mitomycin C in the Prevention of Keloid Scar Recurrence. Archives of Facial Plastic Surgery, 7, 172-175. http://dx.doi.org/10.1001/ archfaci.7.3.172
[23] Baisch, A. and Riedel, F. (2006) Hyperplastic Scars and Keloids. Part I: Basics and Prevention. HNO, 54, 893-904.
[24] Mafong, E. and Ashinoff, R. (2000) Treatment of Hypertrophic Scars and Keloids. Aesthetic Surgery Journal, 20, 114-120. http://dx.doi.org/10.1067/maj.2000.106649
[25] Donkor, P. (2007) Head and Neck Keloids: Treatment by Core Excision and Delayed Intralesional Injection of Steroid. Journal of Oral and Maxillofacial Surgery, 65, 1292-1296.
http://dx.doi.org/10.1016/j.joms.2006.10.049
[26] Alster, T.S. and Tanzi, E.L. (2003) Hypertrophic Scars and Keloids: Etiology and Management. American Journal of Clinical Dermatology, 4, 235-243. http://dx.doi.org/10.2165/00128071-2003 04040-00003
[27] Robles, D.T. and Berg, D. (2007) Abnormal Wound Healing: Keloids. Clinics in Dermatology, 25, 26-32. http://dx.doi.org/10.1016/j.clindermatol.2006.09.009
[28] Poochareon, V.N. and Berman, B. (2003) New Therapies for the Management of Keloids. Journal of Craniofacial Surgery, 14, 654-657. http://dx.doi.org/10.1097/00001665-200309000-00009
[29] Reish, R.G. and Eriksson, E. (2008) Scar Treatments: Preclinical and Clinical Studies. Journal of the American College of Surgeons, 206, 719-730. http://dx.doi.org/10.1016/j.jamcollsurg.2007.11.022

  
comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.